News Archives - Page 665 of 744

ThursdayDec 13, 2018 10:42 am

Spectrum Global Solutions, Inc. (SGSI) Revenues Tracking More than $33 Million Annually, Up from Zero in Early 2017

SSGI posted more than $10 million in revenues in Q3 2018 Growth strategy includes both acquisitions and organic growth through operations Company expects revenue boost from coming 5G mobile service rollout Recently awarded more than $5.7 million in contacts for work on state-of-the-art next-gen communications systems Spectrum Global Solutions, Inc. (OTC: SGSI), a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure and professional service solutions to the service provider (carrier) and corporate enterprise markets, has grown revenues from zero in early 2017 to currently tracking more than $33 million annually, CEO Roger Ponder informed shareholders and investors…

ThursdayDec 13, 2018 10:28 am

Earth Science Tech, Inc. (ETST) Announces that New CBD/Propovit Throat Spray Formula is Close to Market-Ready

Earth Science Tech, via its subsidiaries, centers on developing its role as a global leader in the cannabinoid arena The company’s diverse subsidiaries offer a wide selection of cannabinoid products in numerous categories Earth Science Tech recently announced a CBD/Propovit throat spray formula developed via its partnership with Bionatus A biotechnology enterprise, Earth Science Tech, Inc. (OTCQB: ETST) focuses on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals and medical devices. The company does so through its diverse wholly owned subsidiaries, which concentrate on the development of Earth Science Tech’s role as a worldwide leader in the cannabinoid…

ThursdayDec 13, 2018 10:12 am

Green Hygienics Holdings Inc.’s (GRYN) Science-Driven Cannabis Cultivation Offers Higher Quality at Significantly Lower Cost

Green Hygienics focuses on science-driven cannabis cultivation Its vertical farming process utilizes aeroponic technology The company is at the vanguard of the cannabis sector due to its continuing dedication to invention Targeting the high-end medical and adult-use recreational market, Green Hygienics Holdings Inc. (OTC: GRYN) concentrates on science-driven cannabis cultivation. The company’s growth strategy involves producing revenues from the sales of premium grade cannabis products, developing and licensing valuable intellectual property (IP), making strategic acquisitions and creating trusted global consumer brands. The focus of the Las Vegas, Nevada-based company is pharmaceutical-grade cannabis at higher yields and lower costs. The U.S.…

ThursdayDec 13, 2018 9:55 am

SinglePoint, Inc. (SING) Sees Significant Growth, Triples Revenue Forecast for 2019

Diversified strategy capitalizing on emerging growth opportunities in mobile payments, cannabis and blockchain markets 2018 revenue are expected to top $1 million, while 2019 revenues are expected to triple with additional acquisitions and continued portfolio growth Subsidiary SingleSeed.com added multiple CBD product listings in 2018, organically increasing reach Industrial hemp included in massive 2018 Farm Bill compromise unveiled by lawmakers SinglePoint, Inc. (OTCQB: SING) expects its subsidiary, hemp-CBD distribution line SingleSeed.com, to be one of the company’s top revenue-producing holdings in 2019 – especially with recent news that industrial hemp is firmly rooted in the bipartisan 2018 Farm Bill legislation…

WednesdayDec 12, 2018 12:20 pm

HyreCar Inc. (NASDAQ: HYRE) Offers Mobility as a Service to Rideshare Market

Mobility as a Service market set to hit $358.35 billion by 2025 Ridesharing rental market estimated at 1.25 million drivers and growing 40 percent of aspiring drivers do not own a qualifying car The growth of urban populations with money to spend on automobiles has made driving a nightmare in some cities. In 2010, for example, a massive traffic jam in China that snaked for 100 kilometers (60 mi) lasted for 5 days or longer. Traffic congestion in America’s big metropolises may never reach that scale but their frequency is just as disturbing. However, digitalization may present a way to avoid such…

WednesdayDec 12, 2018 12:06 pm

Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) Revenue for 2018 Up 35 Percent, Further Growth Anticipated

Revenue for the first nine months of the year reached $6.6 million, 35 percent higher than the same period last year Q3 revenue also reached a new record level of $2.4 million In 2019, Kontrol Energy plans to put emphasis on U.S. market smart technology propagation, accretive and strategic acquisitions and acceleration of recurring SaaS revenue In the nine months ended in September 2018, Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) saw an increase in revenue of 35 percent on an annual basis. The revenue for the first nine months of the year was $6.6 million (in comparison to $4.9…

WednesdayDec 12, 2018 11:49 am

ChineseInvestors.com, Inc. (CIIX) Signs LOI for VitaMist, Ltd. Licensing Sales Agreement, Development of Exclusive Vitamin/CBD Spray Line

Strategy is to expand its product line, leverage VitaMist’s branding and longevity, and utilize the company’s spray technology for a delivery system as a future for CBD consumption The LOI is with BCDBG, Inc., parent of VistaMist, for sales by CIIX to the global Asian market; the agreement would give CIIX rights to sell the brand’s organic vitamin spray line Under the agreement, BCDBG would also develop an exclusive and proprietary product line for CIIX that will include vitamin sprays and vitamins/CBD spray combinations ChineseInvestors.com, Inc.’s (OTCQB: CIIX) LOI with BCDBG, Inc. for the global Asian community sales rights to…

WednesdayDec 12, 2018 11:24 am

BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT) Shares the Gift of Good News for Breast Cancer Patients at World’s Largest Breast Cancer Conference

Breast cancer is the leading cancer diagnosed in women, with more than two million new cases diagnosed this year BriaCell Therapeutics advancing prospects of its trademarked Bria-IMT immunotherapy treatment for breast cancer in phase I/IIa trial Company presented data from ongoing trial during San Antonio Breast Cancer Symposium, one of the largest breast cancer conferences in the world The holidays can be a particularly poignant time for receiving a cancer diagnosis as all of society celebrates a season of cheer and shares goodwill with each other, but the San Antonio Breast Cancer Symposium (SABCS), one of the largest breast cancer…

WednesdayDec 12, 2018 10:57 am

Development of First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) North American Assets Shows Prescience as Congo Boosts Costs of Cobalt Traffic

Globe-leading cobalt supplier DRC’s decision to declare metal a strategic resource includes exponential increase in industry tariffs Cobalt is a critical element of computer-powering lithium-ion batteries First Cobalt has North America’s only cobalt refinery capable of producing material suitable for lithium-ion batteries Company is testing varied cobalt feedstocks for suitability as it eyes possibility of restarting the shuttered refinery First Cobalt is also fast-tracking development of its flagship cobalt exploration project in Idaho, with plans to complete updated resource estimate by early 2019 The announcement that government officials in the Democratic Republic of the Congo have signed off on a…

TuesdayDec 11, 2018 12:21 pm

CytoDyn, Inc. (CYDY) Expects FDA Approval for PRO 140 in HIV by Q4 2019, $500M Revenue Forecast for 2020

PRO 140 has FDA fast track designation that allows accelerated approval The drug protects healthy cells from HIV infection by binding to CCR5 cellular co-receptor Market for PRO 140 as a single agent therapy projected at about $4 billion annually CYDY recently initiated its first cancer trial in triple negative breast cancer, targeting an unmet medical need CytoDyn Inc. (OTCQB: CYDY), a biotechnology company focused on the development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV), expects to gain final FDA approval for its HIV treatment, PRO 140, by the fourth…

Site Search

Company Search

Category: News